Nebenwirkungen · Docetaxel Kabi
DOCETAXEL KABI 80 mg/4 ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 73
HOS-214720 · Präparat HOS-155350
Conjunctivitis Ear and labyrinth Hearing impaired disorders Cardiac disorders Myocardial ischemia Arrhythmia (G3/4: 1.7%) (G3/4: 0.6%) Vascular disorders Venous disorder (G3/4: 0.6%) Gastrointestinal Nausea (G3/4: 0.6%); Constipation; disorders Stomatitis (G3/4: 4.0%); Esophagitis/dysphagia/ Diarrhoea (G3/4: 2.9%); odynophagia (G3/4: 0.6%); Vomiting (G3/4: 0.6%) Abdominal pain; Dyspepsia; Gastrointestinal haemorrhage (G3/4: 0.6%) Skin and subcutaneous Alopecia (G3/4: 10.9%) Rash pruritic; tissue disorders Dry skin; Skin exfoliative (G3/4: 0.6%) Musculoskeletal and Myalgia (G3/4: 0.6%) connective tissue disorders General disorders and Lethargy (G3/4: 3.4%); administration site Pyrexia (G3/4: 0.6%); conditions Fluid retention; Oedema Investigations Weight increased
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-08-04T15:44:00Z · SHA-256 4ec115d98d201d84de2340a9fdabdd8a6db17b0a20954d72cafab8a7e3eaf6e6 · Passage e53e44caa1c1cd282278aa9c9dbc15299308b3eafaf272555a8473a0ad259148 · Zeichen 43869–45469 im Abschnitt